1. Home
  2. TWLO vs RMD Comparison

TWLO vs RMD Comparison

Compare TWLO & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Twilio Inc.

TWLO

Twilio Inc.

HOLD

Current Price

$192.32

Market Cap

31.8B

Sector

Technology

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$201.70

Market Cap

28.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWLO
RMD
Founded
2008
1989
Country
United States
United States
Employees
5587
10600
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.8B
28.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TWLO
RMD
Price
$192.32
$201.70
Analyst Decision
Buy
Buy
Analyst Count
24
10
Target Price
$151.54
$292.56
AVG Volume (30 Days)
1.7M
1.4M
Earning Date
04-30-2026
04-30-2026
Dividend Yield
N/A
1.13%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.44
$10.60
Revenue Next Year
$8.21
$7.41
P/E Ratio
$526.76
$25.61
Revenue Growth
N/A
N/A
52 Week Low
$91.84
$180.27
52 Week High
$238.48
$293.81

Technical Indicators

Market Signals
Indicator
TWLO
RMD
Relative Strength Index (RSI) 45.17 49.48
Support Level $179.78 $182.46
Resistance Level $202.50 $260.21
Average True Range (ATR) 10.13 5.43
MACD -2.89 -0.74
Stochastic Oscillator 31.15 33.95

Price Performance

Historical Comparison
TWLO
RMD

About TWLO Twilio Inc.

Twilio is a cloud-based communications platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

Share on Social Networks: